bendamustine hydrochloride has been researched along with Neoplasm Metastasis in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bingman, A; Carothers, S; Kraut, EH; Layman, RM; Lustberg, MB; Lynn, M; Mrozek, E; Ottman, S; Ramaswamy, B; Reinbolt, R; Ruppert, AS; Shapiro, CL; Wesolowski, R | 1 |
Díaz, MG; Dreyling, M; Dyer, MJ; Grigg, A; Knapp, A; Lei, G; Marlton, P; Rule, S; Wassner-Fritsch, E | 1 |
Eichbaum, MH; Foerster, F; Khbeis, T; Lauschner, I; Schneeweiss, A; Schuetz, F; Sohn, C | 1 |
Bamberg, M; Bokemeyer, C; Huober, J; Reichmann, U; Wallwiener, D | 1 |
Anger, G; Brandtner, M; Höffken, K; Merkle, K; Ridwelski, K; Schönfelder, M; Seeber, S | 1 |
Ruffert, K | 1 |
Beyer, J; Bokemeyer, C; Casper, J; Gerl, A; Kanz, L; Kollmannsberger, C; Kuczyk, M; Rick, O; Rie, C; Schleucher, N; Sosada, M | 1 |
6 trial(s) available for bendamustine hydrochloride and Neoplasm Metastasis
Article | Year |
---|---|
Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Breast Neoplasms; CD4 Lymphocyte Count; Dose-Response Relationship, Drug; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lymphopenia; Middle Aged; Neoplasm Metastasis; Nitrogen Mustard Compounds; Quinazolines; Severity of Illness Index | 2013 |
Weekly administration of bendamustine as salvage therapy in metastatic breast cancer: final results of a phase II study.
Topics: Adult; Aged; Antineoplastic Agents; Bendamustine Hydrochloride; Breast Neoplasms; Disease-Free Survival; Female; Follow-Up Studies; Genes, erbB-2; Hematologic Diseases; Humans; Middle Aged; Neoplasm Metastasis; Nitrogen Mustard Compounds; Salvage Therapy; Survival Analysis | 2007 |
Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine.
Topics: Adult; Aged; Antineoplastic Agents; Bendamustine Hydrochloride; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis; Nitrogen Mustard Compounds; Salvage Therapy | 2007 |
Bendamustine as salvage treatment in patients with advanced progressive breast cancer: a phase II study.
Topics: Adult; Aged; Antineoplastic Agents; Bendamustine Hydrochloride; Breast Neoplasms; Humans; Middle Aged; Neoplasm Metastasis; Nitrogen Mustard Compounds; Pilot Projects; Salvage Therapy; Treatment Outcome | 1998 |
[Primary chemotherapy of metastatic breast carcinoma with bendamustine hydrochloride, methotrexate and fluorouracil versus cyclophosphamide, methotrexate and fluorouracil].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Metastasis; Nitrogen Mustard Compounds; Pilot Projects; Salvage Therapy; Survival Rate; Treatment Outcome | 1998 |
Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cisplatin; Cross-Linking Reagents; Drug Administration Schedule; Drug Resistance, Neoplasm; Feasibility Studies; Germinoma; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nitrogen Mustard Compounds | 2000 |
1 other study(ies) available for bendamustine hydrochloride and Neoplasm Metastasis
Article | Year |
---|---|
Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cyclophosphamide; Doxorubicin; Drug Monitoring; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Lymphoma, Follicular; Maintenance Chemotherapy; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prednisone; Survival Analysis; Treatment Outcome; Tumor Burden; Vincristine | 2017 |